Journal
EMBO JOURNAL
Volume 30, Issue 18, Pages 3667-3683Publisher
WILEY
DOI: 10.1038/emboj.2011.307
Keywords
apoptosis; Bcl-2 protein family; cancer therapy; mitochondria; tumourigenesis
Categories
Funding
- Australian NHMRC [461221, 461299, 516703, 637326]
- NIH [CA43540]
- Leukemia and Lymphoma Society [SCOR 7413-07]
- JDRF/NHMRC
Ask authors/readers for more resources
Apoptosis, the major form of programmed cell death in metazoan organisms, plays critical roles in normal development, tissue homeostasis and immunity, and its disturbed regulation contributes to many pathological states, including cancer, autoimmunity, infection and degenerative disorders. In vertebrates, it can be triggered either by engagement of 'death receptors' of the tumour necrosis factor receptor family on the cell surface or by diverse intracellular signals that act upon the Bcl-2 protein family, which controls the integrity of the mitochondrial outer membrane through the complex interactions of family members. Both pathways lead to cellular demolition by dedicated proteases termed caspases. This review discusses the groundbreaking experiments from many laboratories that have clarified cell death regulation and galvanised efforts to translate this knowledge into novel therapeutic strategies for the treatment of malignant and perhaps certain autoimmune and infectious diseases. The EMBO Journal (2011) 30, 3667-3683. doi: 10.1038/emboj.2011.307; Published online 23 August 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available